Translational Research in Pediatric and Obstetric Pharmacology (R01)

archived

Purpose. This funding opportunity announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development encourages research grant applications to conduct studies to improve existing drug saftey and efficacy, and to develop new drugs for pediatric and obstetric populations. The overall goals of this FOA are to support: (1) pharmacological studies addressing the special differences of drug actions and responses among children at various developmental stages, between children and adults, and between pregnant and non-pregnant women; (2) development of new drug targeting children and pregnant women; (3) multidisciplinary collaborations between basic and physician scientists to improve the use of therapeutics in obstetrics and pediatrics. Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) mechanism and runs in parallel with FOAs of identical scientific scope, PAR-09-154 that encourages applications under the R03 grant mechanism and PAR-09-156 that encourages applications under the R21 grant mechanism. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.

High